Advice Page

< Return to Search Results

Drug Details

Drug Number: 435/07
Drug Name: vildagliptin (Galvus)
Drug Manufacturer: Novartis
BNF Category: Endocrine system
Submission type : Full submission
Date Advice Issued: 07 April 2008
Indication: Type 2 diabetes

Drug Advice

vildagliptin (Galvus)

Press Statement

Read the press statement

Link opens in new windowRead the media briefing

Minutes

Read the minutes

Notes

< Return to Search Results

Other SMC Advice for this Drug

There is currently no other SMC advice for this product







Help on how to improve your search.